CompletedNot Applicable

Multicenter Registry Study Of Cerebral Venous Thrombosis In China (RETAIN-CH)

China3,276 participantsStarted 2022-08-20

Plain-language summary

This study will investigate the epidemiology, risk factors, diagnostics, treatment, and the long-term prognosis of cerebral venous thrombosis in China.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Cerebral venous sinus thrombosis, deep cerebral vein thrombosis and cortical vein thrombosis diagnosed by digital subtraction angiography (DSA), magnetic resonance venography (MRV), computed tomography venography (CTV) or high-resolution magnetic resonance imaging (HR-MRI). Exclusion Criteria: * None of the patient, trustee or immediate family members signed the informed consent.

What they're measuring

Favorable clinical outcome (modified Rankin score 0-1)

Timeframe: Baseline to three years

All-cause mortality

Timeframe: Baseline to three years

Trial details

NCT IDNCT05448248

SponsorCapital Medical University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-12-20

View on ClinicalTrials.gov More Cerebral Vein Thrombosis trials